Israeli Researchers Find Genetic Mutation That May Pave Way For Autism Drugs
New research led by Hebrew University Professor Sagiv Shifman studied the effects of POGZ, a gene associated with autism.
January 20, 2021
Israeli Pharma Company Raziel Raises $22M For Development Of Fat-Melting Shot
Israeli pharmaceutical company Raziel Therapeutics announced this week a $22 million Series C preferred stock financing led by Israeli VC firm Pontifax, with the participation of existing investors Dr. Shmuel Cabilly and Docor International. New investors included Catalyst Fund, Quark Venture and Peregrine Ventures. The Jerusalem-based company, founded in 2012 as part of the Hebrew […]
December 19, 2019